| |
| Issue |
Title |
| |
| Vol 65, No 12 (2025) |
Barriers to the Availability and Effectiveness of Cardiac Rehabilitation |
Abstract
PDF (Rus)
|
|
S. A. Pomeshkina, E. A. Demchenko, N. P. Lyamina, M. G. Glezer, O. L. Barbarash |
| |
| Vol 65, No 11 (2025) |
Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP, RSMSI, RAGG |
Abstract
PDF (Rus)
|
|
E. V. Shlyakhto, I. I. Dedov, V. N. Serov, G. T. Sukhikh, G. P. Arutyunov, I. A. Suchkov, O. M. Drapkina, O. N. Tkacheva, Ia. A. Orlova, I. I. Baranov, E. N. Andreeva, S. V. Yureneva, M. I. Yarmolinskaya, A. A. Smetnik, S. V. Villevalde, N. A. Koziolova, I. V. Sergienko, I. S. Yavelov, O. B. Irtyuga, O. R. Grigoryan, E. N. Dudinskaya, I. A. Zolotukhin, E. A. Ilyukhin |
| |
| Vol 65, No 11 (2025) |
Expert Consensus of the Russian Society of Cardiology, the Society of Heart Failure Specialists, the Russian Association of Oncologists, and the Eurasian Association of Cardio-Oncologists. “Cardioprotection 2025: Modern Approaches to Preventing Cardiovasculatoxicity in Antitumor Therapy”. Part II. Primary Prevention of Cardiovasculatoxicity: a Strategy for Protecting the Myocardium and Vessels |
Abstract
PDF (Rus)
|
|
E. V. Shlyakhto, A. D. Kaprin, Yu. N. Belenkov, Yu. A. Vasyuk, N. V. Khabarova, I. S. Ilgisonis, Zh. D. Kobalava, N. A. Koziolova, E. I. Tarlovskaya, V. I. Potievskaya, S. V. Nedogoda |
| |
| Vol 65, No 10 (2025) |
Expert Consensus of the Russian Society of Cardiology, the Society of Heart Failure Specialists, the Russian Association of Oncologists and the Eurasian Association of Cardio-Oncologists. “Cardioprotection 2025: Modern Approaches to Preventing Сardiovasculotoxicity in Antitumor Therapy”. Part I. Introduction, Objectives, Cardiovasculotoxicity Detection Methods and Risk Stratification |
Abstract
PDF (Rus)
|
|
E. V. Shlyakhto, A. D. Kaprin, Yu. N. Belenkov, Yu. A. Vasyuk, N. V. Khabarova, I. S. Ilgisonis, Zh. D. Kobalava, N. A. Koziolova, E. I. Tarlovskaya, V. I. Potievskaya |
| |
| Vol 65, No 3 (2025) |
Possibilities of Optimizing Drug Therapy for Myocardial Infarction: a Consensus on the Use of Type 2 Sodium-Glucose Co-Transporter Inhibitors. Conciliation Document of the Expert Group |
Abstract
PDF (Rus)
|
|
G. P. Arutyunov, S. K. Kononov, N. I. Novitskii, A. N. Baglikov, A. A. Shchendrygina, E. A. Kuzheleva, K. A. Eruslanova, V. A. Safronenko, K. V. Kop’eva, A. E. Soloveva |
| |
| Vol 61, No 10 (2021) |
Expert opinion. Spironolactone: a new twist on an old story |
Abstract
PDF (Rus)
|
|
Ya. A. Orlova, Yu. L. Begrambekova, A. G. Plisuk |
| |
| Vol 61, No 4 (2021) |
Clinical Efficacy and Mechanisms of Actions of the Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and High Risk of Cardiovascular Diseases |
Abstract
PDF (Rus)
|
|
S. R. Gilarevsky |
| |
| Vol 57, No 8 (2017) |
Randomized Controlled Trials in Patients With Heart Failure in Russia Following the Study TOPCAT: What Awaits us in the Future |
Details
PDF (Rus)
|
|
Yuri M. Lopatin |
| |
| 1 - 8 of 8 Items |
|
